Dulac Edward J III (CIK 1821530) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-06). Recent activity: Sell NTLA (4,677 shares), Buy NTLA (61,280 shares), Sell NTLA (6,379 shares), Sell NTLA (7,462 shares), Buy NTLA (47,200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | Sell | 4,677 | $84,186 |
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | Buy | 61,280 | $0 |
| 2026-01-07 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | Sell | 6,379 | $58,751 |
| 2025-07-25 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | Sell | 7,462 | $104,617 |
| 2025-03-04 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | Buy | 47,200 | $0 |
Source: SEC Form 4 filings · as of 2026-07-06